U.S., July 1 -- ClinicalTrials.gov registry received information related to the study (NCT07675226) titled 'Bioequivalence Study of SKI-O-703 in Healthy Adults Under Fed Conditions' on June 23.

Brief Summary: This is an open-label, randomized, crossover Phase 1 study to evaluate the bioequivalence, pharmacokinetics, and safety of two oral SKI-O-703 drugs (test and reference) in healthy adults under fed conditions. Approximately 48 Korean and Caucasian participants will receive a single oral dose of the test drug and a single oral dose of the reference drug in a randomized sequence, separated by a washout period, with pharmacokinetic sampling and safety assessments performed throughout the study.

Study Start Date: July 10

Study Type: INTE...